logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11718612 B1

PDFFull Text
Date of Patent:
Aug. 08, 2023

Filed:

Sep. 08, 2020

Inhibitors of receptor interacting protein kinase i for the treatment of disease

Applicant:

Board of Regents, the University of Texas System, Austin, TX (US);

Inventors:

Richard T. Lewis, Missouri City, TX (US);

Matthew Hamilton, Missouri City, TX (US);

William J. Ray, Houston, TX (US);

Fernando Alvarez, Austin, TX (US);

Naphtali Reyna, Arlington, TX (US);

Jason Cross, Pearland, TX (US);

Suyambu Kesava Vijayan Ramaswamy, Houston, TX (US);

Assignee:

Board of Regents, The University of Texas System, Austin, TX (US);

Attorneys:

Cynthia Hathaway

Lauren L. Stevens

Erik M. Larsen

Primary Examiner:

Shawquia Jackson

Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 471/04 (2006.01); A61K 31/4035 (2006.01); A61K 31/407 (2006.01); A61K 31/415 (2006.01); A61K 31/4172 (2006.01); A61K 31/4196 (2006.01); A61K 31/4245 (2006.01); A61K 31/437 (2006.01); A61K 31/497 (2006.01); A61K 31/4985 (2006.01); A61K 31/5383 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); C07D 209/44 (2006.01); C07D 231/44 (2006.01); C07D 233/90 (2006.01); C07D 249/14 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/407 (2013.01); A61K 31/4035 (2013.01); A61K 31/415 (2013.01); A61K 31/4172 (2013.01); A61K 31/4196 (2013.01); A61K 31/4245 (2013.01); A61K 31/437 (2013.01); A61K 31/497 (2013.01); A61K 31/4985 (2013.01); A61K 31/5383 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); C07D 209/44 (2013.01); C07D 231/44 (2013.01); C07D 233/90 (2013.01); C07D 249/14 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

Find Patent Forward Citations

Lewis, Richard. (2023). Inhibitors of receptor interacting protein kinase i for the treatment of disease (U.S. Patent No. 11718612). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11718612

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…